Charles E Alpers Selected Research

Charles E Alpers Research Topics

Disease

26	Glomerulonephritis 01/2024 - 05/2000
20	Diabetic Nephropathies (Diabetic Nephropathy) 05/2024 - 04/2003
19	Proteinuria 12/2023 - 06/2004
17	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 05/2024 - 04/2002
12	Inflammation (Inflammations) 01/2019 - 02/2003
11	Kidney Diseases (Kidney Disease) 05/2024 - 05/2000
11	Fibrosis (Cirrhosis) 01/2019 - 07/2002
8	IGA Glomerulonephritis (IGA Nephropathy) 12/2023 - 01/2005
7	Type 2 Diabetes Mellitus (MODY) 05/2024 - 09/2010
7	Renal Insufficiency (Renal Failure) 12/2023 - 06/2004
7	Membranous Glomerulonephritis (Membranous Nephropathy) 03/2022 - 08/2002
7	Arteriovenous Fistula 12/2021 - 01/2006
7	Neoplasms (Cancer) 02/2014 - 08/2002
7	Cryoglobulinemia 11/2011 - 04/2002
6	Lupus Nephritis 10/2022 - 06/2004
6	Fistula 12/2021 - 01/2014
5	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 04/2024 - 03/2010
5	Thrombotic Microangiopathies 02/2024 - 05/2000
5	Infections 01/2024 - 04/2002
5	Obesity 07/2023 - 04/2011
5	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 06/2009
4	Atherosclerosis 05/2024 - 01/2008
4	Acute Kidney Injury (Acute Renal Failure) 08/2023 - 01/2004
4	Hyperglycemia 01/2022 - 04/2003
4	Hyperplasia 05/2019 - 08/2002
3	Hypertension (High Blood Pressure) 05/2023 - 06/2008
3	Hypertrophy 01/2022 - 02/2014
3	Hyperlipidemias (Hyperlipidemia) 01/2021 - 01/2004
3	Albuminuria 08/2014 - 05/2009
3	Liver Diseases (Liver Disease) 02/2014 - 03/2007
3	Nephritis 04/2012 - 12/2009
3	Segmental glomerulosclerosis 12/2011 - 08/2002
3	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 06/2011 - 08/2002
3	Wilms Tumor (Wilm's Tumor) 04/2011 - 02/2002
3	Ureteral Obstruction 02/2004 - 05/2003
2	Dyslipidemias (Dyslipidemia) 05/2024 - 01/2018
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2024 - 03/2015
2	Disease Progression 01/2022 - 12/2019
2	Delayed Graft Function 06/2021 - 04/2003
2	Chronic Renal Insufficiency 05/2019 - 06/2005
2	Chronic Kidney Failure (Chronic Renal Failure) 05/2019 - 01/2018
2	Hypoxia (Hypoxemia) 01/2019 - 01/2004
2	Neointima 10/2017 - 01/2006
2	Insulin Resistance 08/2014 - 09/2010
2	Autoimmune Diseases (Autoimmune Disease) 05/2014 - 09/2011
2	Hepatocellular Carcinoma (Hepatoma) 02/2014 - 11/2007
2	Multiple Myeloma 06/2011 - 07/2005

Drug/Important Bio-Agent (IBA)

12	Antigen-Antibody Complex (Immune Complex)IBA 03/2022 - 05/2000
11	Proteins (Proteins, Gene)FDA Link 12/2023 - 10/2003
11	Thymic Stromal LymphopoietinIBA 11/2011 - 04/2002
8	LeptinIBA 05/2024 - 09/2010
8	CreatinineIBA 12/2023 - 01/2005
8	Messenger RNA (mRNA)IBA 02/2021 - 05/2003
7	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 04/2004
7	AutoantibodiesIBA 01/2021 - 06/2004
6	CollagenIBA 05/2019 - 05/2003
5	Angiotensin Receptor AntagonistsIBA 04/2024 - 08/2015
5	sparsentanIBA 04/2024 - 01/2023
5	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2004
5	CryoglobulinsIBA 01/2009 - 04/2002
4	Complement System Proteins (Complement)IBA 05/2024 - 04/2004
4	Endothelins (Endothelin)IBA 04/2024 - 01/2023
4	AntibodiesIBA 10/2018 - 03/2010
4	Immunoglobulin G (IgG)IBA 01/2018 - 05/2009
4	platelet-derived growth factor C (PDGF-C)IBA 02/2014 - 10/2003
4	Chemokine ReceptorsIBA 06/2004 - 05/2000
3	Triglycerides (Triacylglycerol)IBA 05/2024 - 09/2010
3	Immunoglobulin A (IgA)IBA 01/2024 - 01/2005
3	Irbesartan FDA LinkGeneric 12/2023 - 01/2023
3	LDL Receptors (LDL Receptor)IBA 01/2021 - 01/2004
3	Losartan (Cozaar)FDA LinkGeneric 01/2020 - 06/2008
3	DNA (Deoxyribonucleic Acid)IBA 03/2019 - 06/2004
3	ChromatinIBA 03/2019 - 02/2002
3	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2015 - 06/2013
3	Plasminogen Activator Inhibitor 1IBA 02/2014 - 06/2005
3	Transforming Growth Factor beta (TGF-beta)IBA 10/2004 - 05/2003
3	Transforming Growth Factor beta1 (TGF beta 1)IBA 05/2003 - 02/2003
2	Antisense OligonucleotidesIBA 05/2024 - 01/2021
2	ApolipoproteinsIBA 05/2024 - 01/2021
2	Brachyury protein (Brachyury)IBA 07/2023 - 01/2018
2	Blood Glucose (Blood Sugar)IBA 01/2022 - 08/2014
2	LipidsIBA 01/2021 - 08/2014
2	Protein Isoforms (Isoforms)IBA 12/2019 - 01/2008
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2019 - 12/2000
2	CytokinesIBA 10/2018 - 10/2004
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 05/2016 - 04/2016
2	Insulin (Novolin)FDA Link 08/2015 - 08/2014
2	Anti-Bacterial Agents (Antibiotics)IBA 08/2015 - 09/2006
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 08/2015 - 06/2008
2	Serum Amyloid A Protein (Serum Amyloid A)IBA 06/2015 - 03/2015
2	Lipoproteins (Lipoprotein)IBA 05/2015 - 08/2014
2	Streptozocin (Streptozotocin)FDA Link 03/2015 - 04/2003
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2014 - 02/2003
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2013 - 05/2011
2	Caspase 3 (Caspase-3)IBA 04/2011 - 02/2002
2	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2011 - 03/2010

Therapy/Procedure

18	Therapeutics 10/2022 - 04/2002
6	Renal Dialysis (Hemodialysis) 12/2021 - 01/2005
3	Nephrectomy 03/2008 - 08/2002
2	High-Protein Diet 01/2020 - 07/2013